Florent Petitprez
Florent Petitprez
Home
Publications
Experience
Contact
**Florent Petitprez**
Latest
SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome
B cells and cancer: To B or not to B?
Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer
B cells are associated with survival and immunotherapy response in sarcoma
B cells and tertiary lymphoid structures promote immunotherapy response
Tertiary lymphoid structures in the era of cancer immunotherapy
Acute Influenza Infection Promotes Lung Tumor Growth by Reprogramming the Tumor Microenvironment
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
webMCP-counter: a web interface for transcriptomics-based quantification of immune and stromal cells in heterogeneous human or murine samples
Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
Early hepatic lesions display immature tertiary lymphoid structures and show elevated expression of immune inhibitory and immunosuppressive molecules
Context-dependent roles of complement in cancer
Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial
Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome
Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome
Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology
Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth
Revisiting immune escape in colorectal cancer in the era of immunotherapy
MS.liverK: an R package for transcriptome-based computation of molecular subtypes and functional signatures in liver cancer
Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
The clinical role of the TME in solid cancer
Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma
Immune-based identification of cancer patients at high risk of progression
Probing instructions for expression regulation in gene nucleotide compositions
Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine
Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies
Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma
C5 nephritic factors drive the biological phenotype of C3 glomerulopathies
PD-L1 Expression and CD8+ T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate Cancer
Results from a national-wide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy
Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy–associated C3 glomerulopathy
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Cite
×